Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia  Louis L. Nguyen,

Slides:



Advertisements
Similar presentations
Predictive factors of 30-day unplanned readmission after lower extremity bypass James T. McPhee, MD, Neal R. Barshes, MD, MPH, Karen J. Ho, MD, Arin Madenci,
Advertisements

Prospective, randomized, multi-institutional clinical trial of a silver alginate dressing to reduce lower extremity vascular surgery wound complications 
Without prejudice Journal of Vascular Surgery
Revenue cycle management
Outcomes of endovascular lower extremity interventions depend more on indication than physician specialty  Justin R. Wallace, MD, MSc, Theodore Yuo, MD,
Monica S. O'Brien-Irr, MS, RN, Hasan H. Dosluoglu, MD, Linda M
Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia  Andres.
Unplanned return to operating room after lower extremity arterial bypass is an independent predictor for hospital readmission  Faisal Aziz, MD, FACS,
Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010  Grant H. Skrepnek, PhD, David G. Armstrong,
Endoscopic versus open saphenous vein graft harvest for lower extremity bypass in critical limb ischemia  Raymond E. Eid, MD, Li Wang, MS, Michael Kuzman,
Breakthrough: Arthur Blakemore and Arthur Voorhees, Jr
Adjunctive use of the superficial femoral vein for vascular reconstructions  Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,
Hybrid Procedures for Critical Limb Ischemia Have Lower Patency Than Patients Undergoing Standard Femoral-Tibial Bypass With All Autologous Conduit  Graeme.
Comparison of risk factors for length of stay and readmission following lower extremity bypass surgery  Scott M. Damrauer, MD, Ann C. Gaffey, MD, Ann.
Louis L. Nguyen, MD, MBA, MPH  Journal of Vascular Surgery 
Lowell S. Kabnick, MD  Journal of Vascular Surgery 
Predictors and consequences of unplanned hospital readmission within 30 days of carotid endarterectomy  Karen J. Ho, MD, Arin L. Madenci, MD, MPH, Marcus.
Ahmed Kayssi, MD, MSc, MPH, Charles de Mestral, MD CM, PhD, Thomas L
Sumit Gulati, MB Chb, Patrick A
Without prejudice Journal of Vascular Surgery
Michael S. Conte, MD  Journal of Vascular Surgery 
Infected aneurysm of the thoracic aorta
Endoscopic vein harvest does not negatively affect patency of great saphenous vein lower extremity bypass  Sikandar Z. Khan, MD, Mariel Rivero, MD, Brian.
Alexander T. Hawkins, MD, MPH, Anthony J. Pallangyo, MD, Ayesiga M
Thrombolysis for lower extremity bypass graft occlusion
Cryopreserved saphenous vein graft in infrainguinal bypass
The adverse effects of race, insurance status, and low income on the rate of amputation in patients presenting with lower extremity ischemia  Mohammad.
Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical.
Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery  Michael.
Outcomes of reinterventions after subintimal angioplasty
Jayer Chung, MD, J. Gregory Modrall, MD, R. James Valentine, MD 
Prospective, randomized, multi-institutional clinical trial of a silver alginate dressing to reduce lower extremity vascular surgery wound complications 
Utility of direct angiosome revascularization and runoff scores in predicting outcomes in patients undergoing revascularization for critical limb ischemia 
Daniel J. Torrent, MD, MPH, Jill N. Zink, MD, William M. Bogey, MD, C
Open versus endoscopic great saphenous vein harvest for lower extremity revascularization of critical limb ischemia  Vincent J. Santo, MD, Phong T. Dargon,
Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure  Vincent J. Santo, MD, Phong.
Todd R. Vogel, MD, MPH, Gregory F. Petroski, PhD, Robin L. Kruse, PhD 
Risk factors, medical therapies and perioperative events in limb salvage surgery: Observations from the PREVENT III multicenter trial  Michael S. Conte,
Reply Journal of Vascular Surgery
Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: Five-year results of a prospective randomized multicenter clinical trial 
Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD 
Prior contralateral amputation predicts worse outcomes for lower extremity bypasses performed in the intact limb  Donald T. Baril, MD, Philip P. Goodney,
Soma Brahmanandam, MD, MPH, Eric L. Ding, ScD, Michael S
Ramyar Gilani, MD, Roy K. Greenberg, MD, Douglas R. Johnston, MD 
Reviewer Acknowledgment
Plaque excision with the Silverhawk catheter: Early results in patients with claudication or critical limb ischemia  W. Brent Keeling, MD, Murray L. Shames,
James T. McPhee, MD, Louis L. Nguyen, MD, MBA, MPH, Karen J. Ho, MD, C
SS3. Validation of the PIII CLI Risk Score for the Prediction of Amputation-Free Survival (AFS) in Patients with Critical Limb Ischemia  Andres Schanzer,
Composite sequential bypasses to the ankle and beyond for limb salvage
Bhagwan Satiani, MD, MBA, Patrick S. Vaccaro, MD, Michael R. Go, MD 
Long-term prognostic factors after thrombolysis for lower limb ischemia  Monica Kuoppala, MD, Sofia Franzén, MD, Bengt Lindblad, MD, PhD, Stefan Acosta,
Regarding “Vascular abnormalities in patients with neurofibromatosis syndrome type I: Clinical spectrum, management, and results”  John B. Chang, MD,
Surgical and endovascular revision of infrainguinal vein bypass grafts: Analysis of midterm outcomes from the PREVENT III trial  Scott A. Berceli, MD,
James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD 
Long-Term Outcomes of an Endovascular-First Approach for Diabetic Patients With Predominantly Tibial Disease  Caitlin W. Hicks, MD, MS, Joseph K. Canner,
Resource utilization in the treatment of critical limb ischemia: the effect of tissue loss, comorbidities, and graft-related events  Louis L. Nguyen,
Surgical management of severe acute lower extremity ischemia
Reply Journal of Vascular Surgery
Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass.
A pilot, prospective evaluation of a direct thrombin inhibitor, bivalirudin (Angiomax), in patients undergoing lower extremity bypass  Vikram S. Kashyap,
Bhagwan Satiani, MD, MBA, Thomas E. Williams, MD, PhD, Michael R
Marit S. de Vos, BS, Alexander T. Hawkins, MD, MPH, Nathanael D
Determinants of successful peroneal artery bypass
J. David Neel, MD, Robin L. Kruse, PhD, Viktor Y
Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass 
Results of a single center vascular screening and education program
Factors associated with primary vein graft occlusion in a multicenter trial with mandated ultrasound surveillance  Lawrence Oresanya, MD, Anil N. Makam,
Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions  Alan B. Lumsden, MD, Eugene R. Heyman, PhD  Journal.
Lessons learned in adopting the in situ saphenous vein bypass
Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials  Andrew W. Hoel, MD, Ahmed Kayssi, MSc, Soma Brahmanandam,
Presentation transcript:

Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia  Louis L. Nguyen, MD, MBA, MPH, Gregory L. Moneta, MD, Michael S. Conte, MD, Dennis F. Bandyk, MD, Alexander W. Clowes, MD, B. Lynn Seely, MD  Journal of Vascular Surgery  Volume 44, Issue 5, Pages 977-983 (November 2006) DOI: 10.1016/j.jvs.2006.07.015 Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

Fig 1 Quality-of-life changes at 3 months. Journal of Vascular Surgery 2006 44, 977-983DOI: (10.1016/j.jvs.2006.07.015) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions

Fig 2 Quality-of-life changes at 12 months. Journal of Vascular Surgery 2006 44, 977-983DOI: (10.1016/j.jvs.2006.07.015) Copyright © 2006 The Society for Vascular Surgery Terms and Conditions